Mammomat Revelation
2017-11-27
Mammomat Revelation
Nov 26, 2017
The clinical workflow is improved by eliminating the need for a second imaging system and by reducing compression time for the patient.
Did this information help you?
The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Further details are available from the local Siemens Healthineers organizations.
Mammomat Revelation's current FDA approval status is currently "510k pending".
Reference Number: IM2017110125HCEN